Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
Can J Gastroenterol Hepatol. 2022 Jun 21;2022:3421078. doi: 10.1155/2022/3421078. eCollection 2022.
Patients with early gastric cancer undergoing noncurative endoscopic submucosal dissection (ESD) have a risk of tumor recurrence and metastasis, and some patients need additional surgery. The purpose of this study was to explore the risk factors of cancer residue and lymph node (LN) metastasis after noncurative ESD for early gastric cancer and to compare the short outcome of early and delayed additional surgery.
The clinicopathological characteristics of 30 early gastric cancer patients who received noncurative ESD and additional surgery were studied retrospectively. Multivariable regression was utilized to examine the independent risk factors for residual cancer and LN metastasis. Receiver operating characteristic curve was used to analyze the multivariable model's predictive performance. Furthermore, the perioperative safety and radical tumor performance of early surgery (≤30 days, = 11), delayed surgery (>30 days, = 11) after ESD, and upfront surgery ( = 59) were compared.
Multivariable regression showed that diffuse type of Lauren classification, submucosal invasion, and positive human epidermal growth factor receptor-2 (HER-2) were risk factors for residual cancer. Undifferentiated carcinoma, vascular invasion, and positive vertical margin were risk factors for LN metastasis. The area under the curve (AUC) of the multifactor model predicting cancer residue and LN metastasis was 0.761 and 0.792, respectively. The early surgery group experienced higher intraoperative blood loss and a longer operation time than the delayed surgery and upfront surgery groups. There was no significant difference in the number of LN dissections, LN metastasis rate, and postoperative complications among the three groups.
Diffuse type of Lauren classification, submucosal invasion, and positive HER-2 are risk factors for residual cancer, while undifferentiated carcinoma, vascular invasion, and positive vertical margin are risk factors for LN metastasis. Delayed additional surgery after ESD (>30 days) has higher intraoperative safety, without affecting the radical resection in early gastric cancer patients.
接受非治愈性内镜黏膜下剥离术(ESD)的早期胃癌患者有肿瘤复发和转移的风险,部分患者需要追加手术。本研究旨在探讨非治愈性 ESD 治疗早期胃癌后肿瘤残留和淋巴结(LN)转移的危险因素,并比较早期和延迟追加手术的短期结果。
回顾性研究了 30 例接受非治愈性 ESD 及追加手术的早期胃癌患者的临床病理特征。采用多变量回归分析评估肿瘤残留和 LN 转移的独立危险因素。受试者工作特征曲线用于分析多变量模型的预测性能。此外,比较了 ESD 后早期手术(≤30 天,n=11)、延迟手术(>30 天,n=11)和 upfront 手术(n=59)的围手术期安全性和根治性肿瘤效果。
多变量回归显示,Lauren 分类弥漫型、黏膜下浸润和人表皮生长因子受体-2(HER-2)阳性是肿瘤残留的危险因素。未分化癌、血管侵犯和垂直切缘阳性是 LN 转移的危险因素。多因素模型预测肿瘤残留和 LN 转移的曲线下面积(AUC)分别为 0.761 和 0.792。与延迟手术和 upfront 手术组相比,早期手术组术中出血量更多,手术时间更长。三组间淋巴结清扫数目、LN 转移率和术后并发症无显著差异。
Lauren 分类弥漫型、黏膜下浸润和 HER-2 阳性是肿瘤残留的危险因素,而未分化癌、血管侵犯和垂直切缘阳性是 LN 转移的危险因素。ESD 后延迟追加手术(>30 天)具有较高的术中安全性,不会影响早期胃癌患者的根治性切除。